Table 5. Hazard ratios for disease-free survival and overall survival in orthotopic U251 models.
Treatments Compared | Disease-free Survival | Overall Survival | ||
---|---|---|---|---|
HR (95% CI) | P Value | HR (95% CI) | P Value | |
TMZ vs VSR | 2.0 (0.9–5.5) | 0.06 (NS) | 3.0 (1.0–8.8) | 0.0446 |
RT vs VSR + RT | 3.5 (1.2–9.9) | 0.0007 | 9.9 (2.9–34.1) | < 0.0001 |
VSR vs VSR + RT | 2.4 (1.1–8.8) | 0.0244 | 4.5 (2.2–22.5) | 0.0001 |
VSR vs TMZ + RT | 1.2 (0.4–3.2) | 0.66 (NS) | 1.5 (0.5–3.0) | 0.78 (NS) |
VSR + RT vs TMZ + RT | 2.5 (1.0–6.2) | 0.0088 | 3.7 (1.2–11.0) | 0.0198 |
CI: confidence interval; HR: hazard ratio; NS: not significant; RT: radiotherapy; TMZ: temozolomide; VSR: vosaroxin.